|
[Related PubMed/MEDLINE]
Total Number of Papers: 15
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Analysis of patient-specific factors contributing to effectiveness of glucagon-like peptide-1 receptor agonists. |
HbA1c |
| 2 |
2020 |
Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care Databases. |
DPP-4, eGFR, ESKD, SGLT2i |
| 3 |
2020 |
Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies. |
FXR, IR, NAFLD |
| 4 |
2019 |
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease. |
DPP-4, FAO, FXR, IR, NAFLD, NASH, SGLT2 |
| 5 |
2019 |
Post-Basal Insulin Intensification and Healthcare Resource Use in Type 2 Diabetes: A Web-Based Physician Survey in the United States and United Kingdom. |
HCP, T2D, UK, USA |
| 6 |
2019 |
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study. |
DPP-4, HRs, IR, SGLT2, UTIs |
| 7 |
2017 |
Geographical variation in anti-diabetic prescribing in Ireland in 2013 and 2014: a cross-sectional analysis. |
DPP-4, SCV |
| 8 |
2016 |
Mechanisms of improved glucose handling after metabolic surgery: the big 6. |
SGLT2 |
| 9 |
2015 |
Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke. |
--- |
| 10 |
2015 |
Sitagliptin protects rat kidneys from acute ischemia-reperfusion injury via upregulation of GLP-1 and GLP-1 receptors. |
IR |
| 11 |
2014 |
Blood pressure-lowering effects of incretin-based diabetes therapies. |
DPP-4 |
| 12 |
2014 |
Cardiovascular effects of incretin therapy in diabetes care. |
DPP-4, T2DM |
| 13 |
2014 |
Outcomes and treatment patterns of adding a third agent to 2 OADs in patients with type 2 diabetes. |
OADs, T2DM |
| 14 |
2013 |
Evaluating second-line treatment options for type 2 diabetes: focus on secondary effects of GLP-1 agonists and DPP-4 inhibitors. |
CV, DPP-4, T2DM |
| 15 |
2009 |
Ciliary neurotrophic factor recruitment of glucagon-like peptide-1 mediates neurogenesis, allowing immortalization of adult murine hypothalamic neurons. |
CNTF |
|
A Search Service for Abbreviation / Long Form
